Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
UW Health – Spinal Muscular Atrophy
University of Wisconsin Hospital and Clinics600 Highland Ave
Madison, Wisconsin, United States
Phone Web
Our UW Health Kids experts are national leaders in SMA treatment, committed to advancing new therapies for people affected by this life-changing disease. The experts at UW Health and American Family Children’s Hospital are national leaders in SMA treatment. We are committed to advancing new therapies for people affected by this life-changing disease.
At UW Health, we can provide the most current treatment options that best suit both your child and your family’s needs. We are happy to discuss all options, experiences and expectations to aid in this determination.
Our pediatric neurologists are committed to advancing the treatment of SMA through expert, compassionate care and research. We have exceptional experience in treating this condition with a large following at our facility and within our Pediatric Neuromuscular Clinic.
Our SMA specialists see pediatric patients 18-21 years of age at our Pediatric Neurology Clinic at UW Health and at the American Family Children’s Hospital in Madison, after which they can be transferred to the Adult Neuromuscular specialists at UW Health in Madison.
Related Content
-
The Antisense Oligonucleotide Nusinersen for Treatment of Spinal Muscular AtrophySpinal muscular atrophy (SMA) is a rare,...
-
John Hopkins – Spinal Muscular Atrophy (SMA) CenterThe Spinal Muscular Atrophy (SMA) Center...
-
Safety and Efficacy Data Published for Novel Nusinersen Drug Delivery Method for Spinal Muscular Atrophy PatientsA recently published paper details the s...
-
Patient of the Month: GiannaAfter noticing that her daughter was una...
-
Mass General Spinal Muscular Atrophy (SMA) Multidisciplinary ClinicThe Mass General Spinal Muscular Atrophy...
-
Real-World Safety of Nusinersen in Japan: Results From an Interim Analysis of a Post-Marketing Surveillance and Safe...Purpose: Nusinersen is the first disease...
-
STR1VE-EU Trial Shows Efficacy of Onasemnogene Abeparvovec in Spinal Muscular AtrophyOnasemnogene abeparvovec gene replacemen...